Markets | Novartis India shares rise on patent report
Markets | Novartis India shares rise on patent report
Mumbai: Novartis India Ltd’s shares gained in Mumbai after the ‘Business Standard’ newspaper reported the company’s blood-cancer drug Tasigna has been granted a patent. Novartis shares jumped as much as 5.4% to Rs599.95 each before closing at Rs592.40.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!